Stable disease: good news, bad news or neither?

Stable disease means that, on scans compared with earlier ones, the cancer has neither shrunk enough to count as a response nor grown enough to count as progression, and no new areas have appeared. It is one of the four standard response categories defined by agreed rules such as RECIST. Stable disease covers a range: tumours may have shrunk a little, stayed the same size or grown slightly, as long as the change stays within the limits set by the rules. In plain terms, it means the cancer is being held roughly where it was.

Stable disease is one of the most misunderstood results in cancer care. Many people hear "stable" and think treatment is not doing anything, or even that it has failed. In reality, for many cancers, especially advanced cancers where the aim is to control the disease rather than remove it, keeping the cancer stable while you live as well as possible is exactly what treatment is meant to achieve. Without treatment, many of these cancers would be expected to grow. Some treatments, including many targeted medicines, work mainly by stopping growth rather than shrinking tumours, so stable disease is a common sign that they are working.

What happens after a stable result depends on your situation. Often treatment continues, with regular scans to check that the cancer stays controlled. Sometimes, after a set number of cycles with stable disease, the oncologist may suggest a break, a gentler maintenance treatment, or a change if side effects are heavy. If treatment is being given before surgery and the cancer has not shrunk, the team may review the plan. Your oncologist will explain what stable disease means for you. This page explains the term; it cannot interpret your own scan.

Stable is a category, not a verdict

It describes measured change within set limits.

Control is often the goal

In advanced cancer, holding the disease steady can be success.

Treatment frequently continues

Many people carry on the same treatment after a stable result.

It cannot tell you whether your stable disease is a good result for your cancer, or how long it may last. Your oncologist can explain this based on your cancer, treatment and history.

It also cannot give figures about outcomes. These vary widely and belong in a conversation with your oncologist.

Why stable disease can feel unsettling

Living with a cancer that is controlled but still present can be emotionally hard. Some people feel they are waiting for bad news, or find it difficult to explain to family. Counselling and support groups for people living with advanced cancer can help. Many people find ways to plan and enjoy life during long periods of stable disease.

What indicates it matters

Your oncologist looks at stable disease alongside symptoms, blood tests, tumour markers where relevant and how you are coping. Stable scans with improving symptoms and good quality of life are usually a strong reason to continue. Stable scans with heavy side effects may lead to a discussion about adjusting treatment.

Stable disease and treatment breaks

For some cancers, planned breaks after a period of control are safe and give time to recover. Scans continue during breaks, and treatment can restart if needed.

Explaining to family

Family members may hear "no change" as bad news. Explaining that control is often the aim can help.

How stable disease is measured

Radiologists add up the sizes of selected tumours at each scan and compare the total with earlier scans. If the total has not fallen enough to count as a partial response, has not risen enough to count as progression, and there are no new areas, the result is stable disease. This means a report might mention that tumours are slightly smaller or slightly larger, yet still classify the result as stable.

Stable disease with immune treatments

Immune treatments can take longer to work, and tumours sometimes appear stable or even slightly larger before they shrink. Oncologists may continue treatment and repeat the scan to see how things develop.

Stable disease on hormone or targeted tablets

Many tablet treatments for breast, prostate, kidney, lung and other cancers aim to keep the cancer from growing. Long periods of stable disease on these treatments are common and often considered success.

Quality of life matters as much as scans

When the cancer is stable, your oncologist also weighs how well you are living: your energy, appetite, pain, work and family life. If side effects are affecting daily life, options such as reducing amounts, spacing treatments or changing medicines may be discussed.

Planning life with stable disease

Many people with stable disease return to work, travel, attend family events and plan ahead, within the limits of their treatment. Discuss travel or major plans with your team so treatment and scans can be scheduled around them.

Tumour markers during stable disease

Markers may stay steady, rise or fall slightly during stable disease. Your oncologist looks at trends over time rather than single results.

When stable is not the aim

If treatment was intended to shrink a cancer before surgery or radiotherapy, stable disease may prompt the team to consider a different treatment or moving to surgery sooner. Ask what the plan is.

Support for families

Families living alongside long-term cancer control may need their own support. Carer groups and counselling can help.

Keeping track of your results

Keep a simple record of scan dates, result categories and treatment changes, which helps you follow the story of your treatment and prepare questions.

What to do next

Ask whether stable disease is the expected aim, whether treatment will continue, change or pause, how often you will be scanned, and what support is available; and keep reporting new symptoms.